№ lp_2_1_31337
File format: docx Character count: 65030 File size: 177 KB
This guideline addresses pharmacogenetic considerations for antidepressants, detailing how genotypes of CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A may affect drug metabolism, efficacy, and side effects.
Year: 2026
Region / City: Global
Topic: Pharmacogenetics, Antidepressants
Document Type: Guideline
Organization / Institution: Clinical Pharmacogenetics Implementation Consortium (CPIC)
Authors: Chad A. Bousman, James M. Stevenson, Laura B. Ramsey, Katrin Sangkuhl, J. Kevin Hicks, Jeffrey R. Strawn, Ajeet B. Singh, Gualberto Ruaño, Daniel J. Mueller, Evangelia Eirini Tsermpini, Jacob T. Brown, Gillian C. Bell, J. Steven Leeder, Andrea Gaedigk, Stuart A. Scott, Teri E. Klein, Kelly E. Caudle, Jeffrey R. Bishop
Target Audience: Healthcare professionals, geneticists, pharmacologists
Effective Period: Ongoing
Approval Date: 2026
Modification Date: Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.